This web site is part of the Business Intelligence Division of Informa PLC
This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.
Enzon Pharmaceuticals, Inc.
Drug Names(s): PEG-Camptothecin, Prothecan
Description: Prothecan is a PEG-enhanced version of camptothecin. Camptothecin is an anti-cancer compound in the class of drugs called topoisomerase I inhibitors. For many years camptothecin has been known to be a very effective oncolytic agent, but drug delivery problems have limited its use.
Additional information available to subscribers only: